Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination

Oxford COVID Vaccine Trial Group; Kushalinii Hillson; Sue Costa Clemens; Shabir A Madhi; Merryn Voysey; Andrew J Pollard; Angela M Minassian

doi:10.1016/s0140-6736(21)02282-0

Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination

Oxford COVID Vaccine Trial Group, Kushalinii Hillson, Sue Costa Clemens, Shabir A Madhi, Merryn Voysey, Andrew J Pollard, Angela M Minassian^*

^*Corresponding author for this work

Chemical Engineering

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1683-1684
Number of pages	2
Journal	The Lancet
Volume	398
Issue number	10312
Early online date	21 Oct 2021
DOIs	https://doi.org/10.1016/s0140-6736(21)02282-0
Publication status	Published - 6 Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0140-6736(21)02282-0

https://ora.ox.ac.uk/objects/uuid:95aa90fc-eee9-46dd-a589-6108b26c4b06

Cite this

@article{20b3024a7a1b4ed9b39766688da62b3e,

title = "Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination",

author = "{Oxford COVID Vaccine Trial Group} and Kushalinii Hillson and Clemens, {Sue Costa} and Madhi, {Shabir A} and Merryn Voysey and Pollard, {Andrew J} and Minassian, {Angela M} and Christopher Green",

year = "2021",

month = nov,

day = "6",

doi = "10.1016/s0140-6736(21)02282-0",

language = "English",

volume = "398",

pages = "1683--1684",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "10312",

}

TY - JOUR

T1 - Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination

AU - Oxford COVID Vaccine Trial Group

AU - Hillson, Kushalinii

AU - Clemens, Sue Costa

AU - Madhi, Shabir A

AU - Voysey, Merryn

AU - Pollard, Andrew J

AU - Minassian, Angela M

AU - Green, Christopher

PY - 2021/11/6

Y1 - 2021/11/6

U2 - 10.1016/s0140-6736(21)02282-0

DO - 10.1016/s0140-6736(21)02282-0

M3 - Letter

SN - 0140-6736

VL - 398

SP - 1683

EP - 1684

JO - The Lancet

JF - The Lancet

IS - 10312

ER -